4. As of noon trading, C.R. Bard ( BCR) is down $2.58 (-2.0%) to $128.55 on heavy volume. Thus far, 678,062 shares of C.R. Bard exchanged hands as compared to its average daily volume of 567,400 shares. The stock has ranged in price between $128.39-$130.24 after having opened the day at $128.83 as compared to the previous trading day's close of $131.13.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $10.3 billion and is part of the health care sector. The company has a P/E ratio of 73.7, above the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full C.R. Bard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

How Walmart and Costco Could See a Future Flush With Profits Thanks to an Abundance of Cute Puppies

Wall Street Week Ahead: Is Chaos the New Normal?

Healthcare Stocks Sliding on Talks of Revived 'Trumpcare' Bill